HIV-associated progressive encephalopathy of childhood is characterized by
impaired brain growth, decline in cognitive and neurobehavioral performance
s, and progressive motoric dysfunction The diagnosis is based on neurologic
al examination, neuropsychological assessment and cerebral CT or MR imaging
. While the importance of early use of antiretroviral combination therapy h
as been emphasized, limited data exist as to the effect of protease inhibit
ors in children with HIV-associated encephalopathy. We describe the effect
of 3-drug antiretroviral combination therapy, including the protease inhibi
tor nelfinavir, in a 7-y-old girl with vertically acquired HIV infection an
d late onset progressive encephalopathy.